PHARMA NORD ApS
APSActiveCVR 67303016Tinglykke 4-6, 6500 VojensManufacture of other food products n.e.c.· NACE 1089Est. 1981 · 44 years old311 employees
Loading company…
Overview
PHARMA NORD ApS is a Danish APS based in Vojens, operating in the Manufacture of other food products n.e.c. sector. Incorporated in 1981, the company has 311 employees and reported revenue of DKK 518.0m in its latest annual filing.
Revenue 2025
518M DKK
+6% vs 2024
EBITDA margin
7.0 %
−22% vs 2024
Net profit 2025
26.7M DKK
-17% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
38.3 %
AverageAround the average of companies in the same industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
1.0×
WeakAmong the 30% lowest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
5.6 %
AverageAround the average of companies in the same industry
20212025
EBITDA — year on year
DKK millionsKey figures
Annual report 2025| Revenue | 518M DKK | +6% |
| EBITDA | 36.5M DKK | -22% |
| Net profit | 26.7M DKK | -17% |
| Total assets | 473.5M DKK | +17% |
| Equity | 181.4M DKK | +27% |
| Employees | 311 | — |
Company information
Legal name
PHARMA NORD ApS
CVR number
67303016
Legal form
Anpartsselskab
NACE code
Founded
2 October 1981 · 44 years
Share capital
DKK 200,000
Employees
311 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af den samlede direktion eller af den administrerende direktør.
Company purpose
Selskabets formål er handel - herunder eksport, import - produktion samt anden i forbindelse hermed stående virksomhed, bl.a. restaurationsvirksomhed
(no translation available)
Contact
Address
Tinglykke 4-6, 6500 Vojens
Phone
+45 7454 1155
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), PHARMA NORD ApS reported revenue of DKK 518.0m, an increase of 6% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 26.7m, and the EBITDA margin stood at 7%.
At the end of 2025, equity financed 38.3% of the balance sheet, and current assets covered short-term debt 1 times.
Financials
Revenue
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 518,005 | 486,691 | 447,388 | 439,437 | 470,180 |
| Staff expenses | -149,297 | -133,578 | -119,241 | -138,012 | -152,032 |
| EBITDA | 36,473 | 46,720 | 28,340 | 49,523 | 68,941 |
| Depreciation & amort. | -12,718 | -11,427 | -10,734 | -10,875 | -9,852 |
| EBIT | 23,755 | 35,293 | 17,606 | 38,648 | 59,089 |
| Net financials | 7,677 | 4,011 | 8,417 | 4,428 | 11,956 |
| Profit before tax | 31,432 | 39,304 | 26,023 | 43,076 | 71,045 |
| Tax | 4,721 | 7,050 | 2,686 | 7,787 | 13,079 |
| Net profit | 26,711 | 32,254 | 23,337 | 35,289 | 57,966 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 473,514 | 405,332 | 427,094 | 447,011 | 460,569 |
| Equity | 181,417 | 143,344 | 160,565 | 183,029 | 199,348 |
| Long-term debt | 62,149 | 45,723 | 48,409 | 51,067 | 53,734 |
| Short-term debt | 209,419 | 198,067 | 200,416 | 195,687 | 193,481 |
| Total debt | 271,568 | 243,790 | 248,825 | 246,754 | 247,215 |
Financial ratios
5-year trendEBITDA margin
7.0 %
20212025
Equity ratio
38.3 %
AverageAround the average of companies in the same industry
20212025
Return on equity
14.7 %
AverageAround the average of companies in the same industry
20212025
Net profit margin
5.2 %
AverageAround the average of companies in the same industry
20212025
Asset turnover
1.09×
AverageAround the average of companies in the same industry
20212025
Debt / equity
1.61×
WeakAmong the 40% lowest rated companies in the industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginStrong
Among the 40% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginAverage
Around the average of companies in the same industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginAverage
Around the average of companies in the same industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Average
Around the average of companies in the same industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Average
Around the average of companies in the same industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Average
Around the average of companies in the same industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioAverage
Around the average of companies in the same industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioWeak
Among the 30% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioWeak
Among the 30% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioWeak
Among the 30% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery weak
Among the 20% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioAverage
Around the average of companies in the same industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioAverage
Around the average of companies in the same industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityWeak
Among the 40% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityWeak
Among the 40% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtAverage
Around the average of companies in the same industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageAverage
Around the average of companies in the same industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtAverage
Around the average of companies in the same industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginAverage
Around the average of companies in the same industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverAverage
Around the average of companies in the same industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalVery strong
Among the 10% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 40% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the businessNo data on file.
Board of directors
Non-executive oversightNo data on file.
Shareholders
Active legal ownersNo shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
PharmCo III ApS33.33%
PHARMA NORD ApS (this company)PRECISE INGREDIENTS ApS100% ownedTinglykke Byg ApS100% ownedAnpartsselskabet af 9. august 2021100% ownedNutriverse ApS100% ownedFrequently asked questions
What is the CVR number of PHARMA NORD ApS?
PHARMA NORD ApS is registered with CVR / Virk under CVR 67303016.
What is the revenue of PHARMA NORD ApS?
PHARMA NORD ApS reported revenue of DKK 518.0m in 2025.
How many employees does PHARMA NORD ApS have?
PHARMA NORD ApS employs 311 people as of the latest annual report.
Where is PHARMA NORD ApS headquartered?
PHARMA NORD ApS's registered address is Tinglykke 4-6.